Study title: A Study of the Safety and Pharmacokinetics of Nabumetone and 6-MNA, and the Protein Binding of 6-MNA in Patients with Juvenile Rheumatoid Arthritis and in Healthy Adult Volunteers Following Repeated Oral Doses of Nabumetone (1000 mg) Chewable Tablets Report No. SB Document Number: BRL-014 117I RSD1- 00NTK/
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Musculoskeletal Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Nabumetone | |||||
ATC code: M01AX01 | |||||
Document link: Study 222 Nabumetone.xls | |||||
Document date: 2011-09-27 | |||||
Study number: 222 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |